Intravenous fluid therapy is ubiquitous in modern medicine. The range of fluids available for intravenous administration represents a major advance from the early days of intravenous fluids in the 1830s, which began in the midst of the cholera epidemic in London, England. Latta is credited with treating the first patients with intravenous fluids consisting of “two drachms of muriate, and two scruples of carbonate, of soda, to sixty ounces of water” (or 106 mmol/L of Na+, 78 mmol/L of Cl−, and 15 mmol/L of CO32−).1,2 Today, physicians can choose from a large menu of intravenous fluid replacement products: hypotonic, isotonic, and hypertonic crystalloids of varying compositions; synthetic colloids (gelatins, hydroxyethyl starches, dextrans); and human-derived colloids (albumin, fresh-frozen plasma, and red blood cells). The choice depends on the clinical context, physiological considerations, and geographic, institutional, or subspecialty custom.3
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Web of Science® Times Cited: 3
Customize your page view by dragging & repositioning the boxes below.
More Listings atJAMACareerCenter.com >
Enter your username and email address. We'll send you a link to reset your password.
Enter your username and email address. We'll send instructions on how to reset your password to the email address we have on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.